Adicet Bio (ACET) Capital Expenditures (2017 - 2026)
Adicet Bio (ACET) posted quarterly Capital Expenditures of $37000.0 for Q1 2026, up 137.0% year-over-year from $15611.8 in Q1 2025, and up 470.0% quarter-over-quarter from -$10000.0 in Q4 2025.
Adicet Bio (ACET) Capital Expenditures (2017 - 2026) Analysis & Trends
Adicet Bio's Capital Expenditures history runs 10 years deep, the most recent figure standing at $37000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 137.0% year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 619.39% YoY), while the FY2025 annual figure was $1.7 million, up 592.35% from the prior year.
- Capital Expenditures for Q1 2026 stood at $37000.0, up from -$10000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $3.7 million in Q3 2023, with the low at -$5.4 million in Q3 2022.
- The 5-year median for Capital Expenditures is $37000.0 (2026), against an average of $291588.2.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures slumped 318.79% in 2022, then surged 3300.0% in 2023.
- Adicet Bio's Capital Expenditures stood at $4000.0 in 2022, then soared by 3300.0% to $136000.0 in 2023, then slumped by 155.88% to -$76000.0 in 2024, then surged by 86.84% to -$10000.0 in 2025, then jumped by 470.0% to $37000.0 in 2026.
- Business Quant data shows ACET's Capital Expenditures at $37000.0 in Q1 2026, -$10000.0 in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 75,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75,000.00 |
| Jun 30, 2026 | 75,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Sep 30, 2024 | -818,000.00 |
| Sep 30, 2024 | -818,000.00 |
| Jun 30, 2024 | 633,000.00 |
| Jun 30, 2024 | 633,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Mar 31, 2024 | -92,000.00 |